Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Therapix Biosciences Ltd ADR
TRPXY
Healthcare
Biotechnology
Therapix Biosciences Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several innovative immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The operating segments of the group are Development of drugs based on cannabinoid...
molecules to be approved by an official regulatory authority (the Company's operation); and Pain clinic
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (OTCPK:TRPXY)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
Next
(10)
•••
edmed
X
View Profile
View Bullboard History
Post by
edmed
on Jul 08, 2020 11:25am
CARMA
used to own this a year ago they had a chance to do a deal with FSD pharma and make some money for their shareholders unfortunately it looks like their EGOs got in the way glad I got out with just a
...more
(4)
•••
tony27
X
View Profile
View Bullboard History
Post by
tony27
on May 12, 2019 4:08pm
Fsd pharma
All you people on this board need fsd to buy you again. Otherwise you are a useless company with no cash. And they said Huge was a bad company. This company sucks and I love it .
(2)
•••
StuinSea
X
View Profile
View Bullboard History
Comment by
StuinSea
on Mar 29, 2019 7:40pm
RE:RE:Can anyone tell me if
Yup, you're right!
(0)
•••
Fundy13
X
View Profile
View Bullboard History
Comment by
Fundy13
on Mar 29, 2019 2:15pm
RE:Can anyone tell me if
Think you might be on the wrong board, SNN is spinning off Cdn and US
(2)
•••
StuinSea
X
View Profile
View Bullboard History
Post by
StuinSea
on Mar 29, 2019 1:35pm
Can anyone tell me if
they ever did any work at all on the Canadian project? I know they plan on spinning off the Canadian assets.
(0)
•••
Fundy13
X
View Profile
View Bullboard History
Post by
Fundy13
on Mar 29, 2019 11:11am
Staying put
Sellers have dried up already. I think we drift up to $3.50 next week. Still curious who was doing all the buying on Feb 04 and 05 when we traded 700,000 shares in two days. 20% of the
...more
(0)
•••
Fundy13
X
View Profile
View Bullboard History
Comment by
Fundy13
on Mar 28, 2019 1:43pm
RE:RE:stopped out today
I knew financing was a good possibility and I knew the stock price woudl likely drop if that happened. What has surprised me is how big a difference in financing this time compared to last.
...more
(2)
•••
Mining_Engineer_UBC
X
View Profile
View Bullboard History
Comment by
Mining_Engineer_UBC
on Mar 28, 2019 12:53pm
RE:stopped out today
I feel your pain edmed. And its an act of courage to sell at what I'm assuming is a loss. For others still holding TRPX I will say that although this financing deal is not on the greatest of terms
...more
(0)
•••
Fundy13
X
View Profile
View Bullboard History
Comment by
Fundy13
on Mar 28, 2019 12:48pm
RE:stopped out today
I agree, they would have been better off accepting reduced terms from FSD Pharma then doing this bad deal. Even if they took a buyout at 50% of the original $48million offer that would be double
...more
(10)
•••
edmed
X
View Profile
View Bullboard History
Post by
edmed
on Mar 28, 2019 11:32am
stopped out today
I won't be back the whole thing has been very disappointing edmed
(0)
•••
Fundy13
X
View Profile
View Bullboard History
Comment by
Fundy13
on Mar 28, 2019 10:52am
RE:More News
Another short term band aid, not what I wanted to see. If they were gong to do financing I thought it would be for enough to get them through a couple years of research. This is just another 3-6
...more
(2)
•••
StuinSea
X
View Profile
View Bullboard History
Post by
StuinSea
on Mar 28, 2019 9:12am
More News
https://seekingalpha.com/news/3446463-therapix-bio-18-percent-pricing-registered-direct-offering?dr=1#email_link Therapix Bio down 18% on pricing registered direct offering Mar. 28, 2019 9:07
...more
(2)
•••
StuinSea
X
View Profile
View Bullboard History
Comment by
StuinSea
on Mar 28, 2019 8:36am
RE:RE:6K 03/26 Not good
I guess if they could find a buyer that would be great, but this quote "Due in part to significant losses incurred by THR, as well as its failure to maintain required licenses to operate its
...more
(0)
•••
Fundy13
X
View Profile
View Bullboard History
Comment by
Fundy13
on Mar 27, 2019 1:30pm
RE:6K 03/26 Not good
I do not see that as being very important. This stock comes down to one thing. Do they find a buyer or not. The research they have done is easily worth more than the current market cap, however
...more
(2)
•••
StuinSea
X
View Profile
View Bullboard History
Post by
StuinSea
on Mar 26, 2019 7:47pm
6K 03/26 Not good
https://fintel.io/doc/sec-trpx-therapix-biosciences-6k-2019-march-26-17981 Anticipated Liquidation of Therapix Healthcare Resources, Inc. On July 26, 2018, and as amended in July, August
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Why Dozens of Pro Athletes are Paying Attention to this Product
BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide
Debt-Free Cannabis Company Set for Next Stage of Growth
Growth Rocket 2025 – Why dynaCERT is in the Spotlight
A potential breakthrough in spinal cord and optic nerve injury treatment
Learn How this Company is Disrupting Point-of-Care Testing